Jonathan Alspaugh Net Worth & Insider Trades

Jonathan Alspaugh - Chief Financial Officer, Aeglea Biotherapeutics, Inc

As of March 15, 2022

What is Jonathan Alspaugh's Net Worth?

The current estimated net worth of Aeglea Biotherapeutics, Inc's Chief Financial Officer, Jonathan Alspaugh, is estimated to be about $29.47K . Jonathan Alspaugh owns about 165,372 units of Aeglea Biotherapeutics, Inc common stock. In the last year at Aeglea Biotherapeutics, Inc, Jonathan Alspaugh has sold an estimated value of $0 worth.

What is Jonathan Alspaugh's Past Insider Trading?

Jonathan Alspaugh's largest purchase order was 40,372 units , worth over $262.66K on August 18, 2021. In total, Jonathan Alspaugh has made about 5 transactions over a year of their time at Aeglea Biotherapeutics, Inc. Jonathan Alspaugh usually trades in December, August, February, July and March, with the busiest year in 2021. The most recent transaction was a purchase order of 75,000 units , worth over $156K on March 15, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Jonathan Alspaugh's' Mailing Address?

  • Mailing address is C/o Aeglea Biotherapeutics, Inc. 805 Las Cimas Parkway, Suite 100 Austin TX 78746 TX

Aeglea Biotherapeutics, Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Anthony G. Quinn, M.B Ch.B, Ph.D. 2020 $538,000 $2,089,861 $2,089,861 $25,745 $2,909,606
Anthony G. Quinn, M.B Ch.B, Ph.D. 2019 $518,000 $1,663,919 $1,663,919 $53,857 $2,482,776
Charles N. York II 2020 $415,000 $860,415 $860,415 $8,053 $1,283,468
Charles N. York II 2019 $390,000 $522,424 $522,424 $7,712 $1,085,136
Leslie Sloan, Ph.D. 2020 $370,000 $707,970 $707,970 $20,349 $1,246,319
Leslie Sloan, Ph.D. 2019 $355,000 $632,380 $632,380 $19,843 $1,149,223
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1636282/000156459021019953/agle-def14a_20210608.htm

What are Aeglea Biotherapeutics, Inc's Past Insider Trades?

Aeglea Biotherapeutics, Inc's most recent insider trade came on June 10, 2022 by Conick Michael Hanley Jr who bought 28,200 units worth $20.02K . In the last 6 years, insiders at Aeglea Biotherapeutics, Inc have sold an estimated value of $1.43M and bought an estimated value of $13.66M worth of shares. Insider trading is most common in June, with the busiest year in 2018 and 2017. The most active traders at the company are Anthony Quinn, President & CEO,  Armen Shanafelt, Director,  and Charles N. York II, Chief Financial Officer and VP .

Aeglea BioTherapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1